Leveraging the nice face of Janus kinase inhibition-ruxolitinib cream in atopic dermatitis
- PMID: 31870763
- DOI: 10.1016/j.jaci.2019.12.012
Leveraging the nice face of Janus kinase inhibition-ruxolitinib cream in atopic dermatitis
Keywords: Atopic dermatitis; biologics; microbiome.
Comment on
-
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.J Allergy Clin Immunol. 2020 Feb;145(2):572-582. doi: 10.1016/j.jaci.2019.08.042. Epub 2019 Oct 17. J Allergy Clin Immunol. 2020. PMID: 31629805 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous